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Pre-treatment with blockers and the frequency of
hypokalaemia in patients with acute chest pain
ELLIOTT SIMPSON,* J CHRISTINE RODGER,t S MAHENDRA RAJ,t
CHRIS WONG,t LAURA WILKIE,*t CHRISTOPHER ROBERTSON:
From the Departments of *Biochemistry and tMedicine, Monklands District General Hospital, Airdrie,
Lanarkshire and tDepartment of Mathematics, University of Strathclyde, Glasgow
SUMMARY Plasma potassium concentration was measured at admission in 1234 patients who
presented with acute chest pain. One hundred and ninety five patients were on P blockers before
admission. The potassium concentrations of patients admitted early (within four hours of onset
of symptoms) were compared with those admitted later (4-18 hours after onset of symptoms).
There was a transient fall in plasma potassium concentrations in patients not pre-treated with ,B
blockers. This was not seen in patients who had been on P blockers before admission. Non-
selective ,B blockers were more effective than cardioselective agents in maintaining concentrations
of plasma potassium.
These findings suggest a mechanism for the beneficial effects of ,B blockers on morbidity and
mortality in acute myocardial infarction.
There is speculation that the hypokalaemia of myo-
cardial infarction is adrenaline induced and that #
blockade, given early, may be effective in preventing
or attenuating it.1 In the present study we in-
vestigated whether pre-treatment with # blockers
can maintain plasma potassium concentrations and
reduce the frequency of hypokalaemia in patients
admitted with ischaemic chest pain.
Patients and methods
We measured the initial concentration of plasma
potassium in 1234 consecutive patients at admission
to the cardiac care unit. The plasma was separated
with minimum delay (less than one hour) and analy-
sed by flame photometry. All patients had acute
chest pain: 432 had evidence of acute myocardial in-
farction and the remainder were considered to have
acute myocardial ischaemia. Before admission, 126
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patients were on a # blocking agent, 270 were on a
diuretic, and an additional 69 were on both a ,B
blocker and a diuretic; the remaining patients were
on neither of these drugs. No patient was given a #
blocker in hospital before the initial blood specimen
was taken.
The case records of 1010 of the patients were ex-
amined retrospectively to establish the times from
onset of symptoms to sampling. There is no reason
to believe that these patients are unrepresentative of
the total group.
Statistical methods
We used factorial analysis of variance models2 to in-
vestigate the effects of the following factors on
plasma potassium concentrations: (a) the nature of
the presenting condition (that is infarction or
ischaemia); (b) the time from onset of symptoms to
sampling; (c) the presence or absence of diuretics;
and (d) the presence or absence of a ,B blocker.
Because the distribution of potassium values was
positively skewed we used log potassium values to
calculate confidence intervals and tests of sig-
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Table 1 Concentration ofplasma potassium on admission in
patients with acute chest pain
Hypokalaemic
Data No Mean (ISD) (%)
No drugs 769 3-941 (0 464) 11 7
blockers alone 126 3-959(0.421) 71
Diuretics alone 270 3-758 (0 544) 26-6
f blockers and diuretics 69 3-736(0 602) 37-6
Total 1234 3-891(0 494) 16 0
Cardioselective ,B
blockers alone 74 3 901(0-346) 6 7
Non-selective f blockers
alone 52 4 042(0 501) 7-6
Cardioselective f
blockers and diuretic 44 3 709(0-531) 34 0
Non-selective ,B blockers
and diuretic 25 3-784(0 720) 44 0
nificance. Because this produced very similar results
to those obtained using the raw data untransformed
means and standard deviations of plasma potassium
values (mmol/l) are given in the tables. The
differences in means given in the text are derived
from the factorial analysis with log transformation,
and are thus not identical to the differences obtained
by subtraction of the arithmetic means given in the
tables.
We used a logit model for a parallel analysis of the
proportion of patients with hypokalaemia on admis-
sion; this is the standard method for investigating
the effects of multiple factors on proportions.3
Results
Table 1 sets out the results for all 1234 patients
taking no account of the time from onset of symp-
toms to sampling and analysing the infarction and
500
ischaemic groups together. These results show that
there was no significant difference between the mean
plasma potassium concentrations or the frequency of
hypokalaemia (potassium < 3-5 mmol/l) in patients
on blockers alone (both cardioselective and non-
selective) and in those on no drug treatment at the
time of admission. Neither was there any significant
difference in the mean potassium concentrations in
patients on cardioselective and non-selective P
blocking agents. Patients on diuretics had a
significantly lower mean potassium (mean difference
018mmol/l, 95% confidence interval (CI) 011 to
0 26, p < 0-001) and a significantly higher frequency
of hypokalaemia (mean difference 15%, 95% CI 9 to
21%, p < 0 001) than those on no drug treatment.
There was no significant difference between the
mean potassium concentrations in patients on both a
# blocker and a diuretic and in those on a diuretic
alone. Mean potassium concentrations in patients on
a cardioselective agent and a diuretic were not
significantly different from those in patients on a
non-selective agent and a diuretic.
In table 2 the results for patients with acute myo-
cardial infarction and myocardial ischaemia are
considered separately. The mean plasma potassium
concentrations in patients with myocardial infarc-
tion and those with myocardial ischaemia were not
significantly different. In the absence of drug treat-
ment, however, the frequency of hypokalaemia is
higher in the infarct group than in the ischaemic
group (mean difference 5%, 95% CI 0% to 9%,
p < 0 07). Thus when no account was taken of the
time from onset of symptoms to sampling, no
significant effect of pre-treatment with # blockers on
the mean potassium concentrations or on the fre-
quency of hypokalaemia was demonstrated; this held
for patients on diuretics as well as those on no drug
treatment. Pre-treatment with diuretics is associated
Table 2 Concentration ofplasma potassium on admission in patients with acute myocardial infarction and patients with
myocardial ischaemia
Myocardial infarction Myocardial ischaemia
Data No Mean (ISD) Hypokalaemia (hO) No Mean (ISD) Hypokalaemia (Oo)
No drugs 305 3-942 (0 483) 14 4 464 3 940(0 452) 9-9
,B blockers alone 42 3-980(0-510) 16-6 84 3-948 (0-371) 2-3
Diuretics alone 60 3-826 (0 704) 31 6 210 3-739 (0-489) 25 2
blockers and diuretics 25 3 724(0 522) 36-0 44 3-743(0 649) 38 6
Total 432 3 917 (0 526) 18 3 802 3-877 (0-476) 14 7
Cardioselective P blockers alone 24 3-925 (0-452) 16 6 50 3-890(0 286) 2-0
Non-selective ,B blockers alone 18 4 055 (0-585) 16-6 34 4 035 (0-461) 2-9
Cardioselective ( blockers and
diuretic 15 3-753(0 530) 26 6 29 3-686(0 539) 37 9
Non-selective ,B blockers and
diuretic 10 3-680(0 534) 50-0 15 3 853(0-832) 40 0
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Table 3 Concentration ofplasma potassium on admission in patients with acute chest pain. Valuesfor those admitted within
4 hours of onset ofsymptoms are compared with valuesfor those admitted 4 to 18 hours after onset
Admitted within 4 hours Adnmtted 4-18 hours
Data No Mean (ISD) Hypokalaemic (%) No Mean (ISD) Hypokalaemic (%)
No drugs 351 3-879(0 464) 16-5 215 4-011(O-389) 5-1
,B blockers alone 61 4-068(0 507) 3-2 62 3 909(0 352) 8-0
Diuretics alone 143 3 709(0 542) 25-8 107 3-769 (0.476) 25-2
0 blockers and diuretics 39 3-784(0 693) 38-4 32 3-731 (0 530) 28-1
Total 594 3-851(0-514) 18-9 416 3-912(0-434) 12-5
Table 4 Concentration ofplasma potassium on admission in patients with acute myocardial infarction. Valuesfor those
admitted within 4 hours of onset ofsymptoms are compared with valuesfor those admitted 4 to 18 hours after onset
Admitted within 4 hours Admitted 4-18 hours
Data No Mean (ISD) Hypokalaemic (%) No Mean (ISD) Hypokalaemic (%)
No drugs 163 3-875 (0-515) 20-2 80 4-007(0 406) 7-5
, blockers alone 18 4-183(0-697) 11 1 24 3 845(0398) 16-6
Diuretics alone 30 3 540(0 454) 30 0 26 3-942(0 656) 30 7
I blockers and diuretics 14 3-792(0 782) 42-8 14 3-807(0-451) 14-2
Total 225 3-850(0 560) 22-2 144 3-949(0 465) 13-9
Table 5 Concentration ofplasma potassium on admission in patients with acute myocardial ischaemia. Valuesfor those
admitted within 4 hours of onset of symptoms are compared with valuesfor those admitted 4 to 18 hours after onset
Admitted within 4 hours Admitted 4-18 hours
Data No Mean (ISD) Hypokalaemic (%) No Mean (ISD) Hypokalaemic (%)
No drugs 188 3-883(0-416) 13-2 135 4-014(0-381) 3-7
,B blockers alone 43 4-020(0 403) 0.0 38 3 950 (0-319) 2-6
Diuretics alone 113 3-754(0 556) 24-7 81 3-713(0-391) 23-4
,B blockers and diuretics 25 3-780(0 655) 36-0 18 3-672(0 589) 38-8
Total 369 3 852(0 485) 16-8 272 3-893(0-416) 11-8
with a significant reduction in plasma potassium and
a significant increase in the frequency of hypo-
kalaemia on admission.
Table 3 examines the effect of time from onset of
symptoms to sampling, but without separate
analysis of acute myocardial infarction and
ischaemia. In patients on no drug treatment those
admitted within four hours of symptoms had a lower
mean plasma potassium concentration (mean
difference 0-13mmol/l, 95% CI 0 07 to 0-22,
p < 0 001) and a higher frequency of hypokalaemia
(mean difference 11%, 95 CI 6 to 16, p < 0 01) than
those admitted after four hours. A rise in plasma
potassium with time may thus be inferred. A rise in
mean plasma potassium with time may similarly be
inferred in patients pre-treated with diuretics alone
but not in patients pre-treated with ,B blockers. In
patients admitted within four hours of the onset of
symptoms, pre-treatment with # blockers was asso-
ciated with a higher mean plasma potassium (mean
difference 0.14mmol/l, 95% CI 0 05 to 0-23,
p < 0 01) and a lower frequency of hypokalaemia
than no drug treatment (mean difference 160%, 950%
CI 4 to 45, p <001).
Tables 4 and 5 present the results for infarct and
ischaemic patients and fig 1 shows the differences in
mean plasma potassium concentrations.
For patients with myocardial infarcts who were
admitted within four hours the mean potassium con-
centration was significantly higher in those on #
blockers than in those on no drugs, and patients on
both a # blocker and a diuretic had a higher mean
potassium concentration than those on diuretics
alone (mean difference 0 27 mmol/l, 95% CI 0-05 to
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4.21(® MyocCardicil ischaelmia
Patients on no drug treatment
Patients on P blockers only
Patients on diuretics only
_ Patients on diuretics and p blockers
C4h 4-18h <4h 4-18h
Fig 1 Concentrations ofplasma potassium on admission in patients admitted withinfour hours of onset ofsymptoms and
patients admitted 4-18 hours after onset. (a) In patients with acute myocardial infarction and (b) in patients with
myocardial ischaemia.
M Patients not on diuretics
M Patients also on diuretics
No P blocker Cardiose(ective Non-selective
0.5, p < 0 05). For ischaemic patients admitted
within four hours, the mean plasma potassium in
those on P blockers was also higher than in those on
no drugs, but this difference was not significant
(mean difference OlOmmol/l, 95% CI -0.03 to
0-23, p < 0-15). For both infarct and ischaemic
patients admitted 4-18 hours after onset, the mean
potassium concentration in patients on P blockers
was not significantly different from those on no drugs.
Figure 2 compares the influence of cardioselective
and non-selective ,B blockers on mean plasma potas-
sium concentrations. No significant effect of cardio-
selective /3 blockers on mean plasma potassium was
demonstrated. The effect of non-selective /3 blockers
on mean plasma potassium concentration was
evident in patients admitted within four hours of on-
set of symptoms. In this group the mean potassium
concentration in patients on non-selective /3 blockers
was significantly higher than in those on no drugs
and similarly those on non-selective P blockers and
diuretics had a higher mean potassium than those on
diuretics alone (mean difference 0 25 mmol/1, 95%,
CI 0-08 to 0.43, p < 0 01).
Fig 2 Concentrations ofplasma potassium on admission in
patients admitted with acute chest pain withinfour hours of
onset of symptoms and pretreated cardioselective or
non-selective P blockers.
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Discussion
Although the effect on plasma potassium concen-
trations of intravenous blockade introduced after
the onset of acute myocardial infarction has been
studied,45 little is known about what happens to
plasma potassium concentrations in patients who are
already on blockers at the time of their infarction.
In analysing our findings we have combined
results from patients with acute myocardial infarc-
tion and myocardial ischaemia. We consider that
this approach is justified, firstly because there was
no significant difference between the mean plasma
potassium concentrations for infarct and ischaemic
patients in any of the subgroups, and secondly
because, though the frequency of hypokalaemia in
our ischaemic patients was less than that in infarct
patients, it was not negligible. The frequency of
hypokalaemia in patients admitted with ischaemic
chest pain has not been reported before; however,
the frequency of hypokalaemia in acute myocardial
infarction in this study was similar to that reported
by others.6 '
The hypokalaemia that was found was mild
in most instances, and only 2% of patients had
plasma potassium concentrations on admission of
< 3 0 mmol/l. But plasma potassium concentrations
between 3 0 and 35 mmol/l can predispose to
ventricular arrhythmias,8 and mild hypokalaemia
cannot be dismissed as clinically unimportant.
Table 1 shows that, if no account is taken of the
time from onset of symptoms to sampling, it is not
possible to demonstrate an effect of blockers on
plasma potassium concentrations. Provided that
time is taken into account, as in table 3, # blockers
can be shown to maintain potassium concentrations
and reduce the frequency of hypokalaemia. This
effect, however, is evident only shortly after the
onset of symptoms (in this study within four hours).
There are two possible explanations for this. One is
that as the hypokalaemia is transient, lasting for
hours only and resolving spontaneously,9 the
beneficial effect of pre-treatment with blockers can
only be expected during the early stages when the
plasma potassium would otherwise be low.The other
possible explanation is that plasma concentrations of
the blockers may be lower in patients who are
admitted later.
Our findings are consistent with the hypothesis
that the hypokalaemia of acute myocardial infarction
is adrenaline induced. Our findings also have prac-
tical implications: they suggest that should myo-
cardial infarction or ischaemia occur in patients
already on a blocker (whether for hypertension or
after infarction) normokalaemia is more likely to be
maintained, and ventricular arrhythmias may be
,B blockers and hypokalaemia
thus less likely to occur than in patients who are not
similarly pre-treated.
In the only previous study that is directly com-
parable to ours: pre-treatment with # blockers had no
effect on plasma potassium concentrations in a
group of nine patients with acute myocardial infarc-
tion.5 In the light of our present findings, this was to
be expected as the mean time from the onset of
symptoms to admission in this group was greater
than four hours.
Others have looked at the effects on potassium
concentrations of intravenous # blockers introduced
after the onset of myocardial infarction.4 5 The
design of these studies is different from ours and the
practical implications of the results are also
different. None the less, these two approaches do
lead to the same broad conclusion, that is that #
blockade can favourably influence potassium con-
centrations in patients with acute myocardial infarc-
tion. Because Nordrehaug et al used a definition of
hypokalaemia (,<3.5 mmol/1)4 that is wider than
usual (<3 5mmol/1) their study may be open to
criticism. Also we have been unable to reproduce the
statistical results reported in their table II: in partic-
ular we did not achieve any significant probabilities
smaller than 5% when we used the appropriate two
tailed Fisher's exact test.
We showed that non-selective # blockers were
more effective than cardioselective /3 blockers in
maintaining plasma potassium concentrations. This
is in keeping with the results of experimental studies
which showed that adrenaline-induced hypo-
kalaemia may be prevented by non-selective # block-
ade and attenuated by cardioselective /3 blockade.10
Studies in normal volunteers have shown that in-
fused adrenaline and pre-treatment with diuretics
have additive hypokalaemia effects." In keeping
with this additive effect, we found that # blockers
did, to some extent, maintain plasma potassium in
patients who were also on diuretics. Overall, how-
ever, the frequency of hypokalaemia in patients on
both / blockers and diuretics in this study was sub-
stantial, and concurrent # blockade cannot be
regarded as an adequate protection against diuretic
induced hypokalaemia. This is exemplified by the
frequency of hypokalaemia reported in patients on
proprietary preparations of combined / blockers and
diuretics,'2 13 and, indeed, in this study nine (47%)
of 19 patients on such proprietary preparations were
hypokalaemic.
We were able to show that- pre-treatment with /3
blockers can maintain plasma potassium concen-
trations and attenuate hypokalaemia in patients with
acute ischaemic chest pain. These results suggest
one possible mechanism for the beneficial effects of /3
blockers on morbidity'4 and mortality 145 in acute
 group.bmj.com on May 11, 2010 - Published by heart.bmj.comDownloaded from 
Simpson, Rodger, Raj, Wong, Wilkie, Robertson 504
myocardial infarction. They also suggest a possible
mechanism for the long term reduction in mortality
(reinfarction and sudden death) that has been
observed in patients on prophylactic ,3 blockade
after myocardial infarction. 16 17
LW was supported by a grant from Astra Pharma-
ceuticals Ltd.
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